7,606.90

+26.83

+0.35%

52,272.50

+502.19

+0.97%

25,513.37

+76.37

+0.30%

2,837.50

+25.65

+0.91%

4.8780

-0.0510

-1.03%

19.05

-0.37

-1.91%

3,974.30

+75.40

+1.93%

76,881.34

-972.65

-1.25%

Crude Oil Dec 26

96.57

-7.55

-7.25%

US Private Equity

10,850.63

-82.20

-0.75%

Toronto - Free Realtime Quote CAD

COSCIENS Biopharma Inc. (CSCI.TO)

8.50 +0.10 (+1.19%)

As of 10:55:04 AM EST. Market Open.

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

COSCIENS ANNOUNCES NEW CORPORATE PRESENTATION AND PROVIDES UPDATE ON CONVERTIBLE DEBENTURE OFFERING

GlobeNewswire 14d ago

CSCI.TO
+1.19%
CSCIF
COSCIENS COMPLETES SECOND TRANCHE OF CONVERTIBLE DEBENTURE OFFERING

GlobeNewswire 1mo ago

CSCI.TO
+1.19%
CSCIF
COSCIENS ACQUIRES NUALTIS CORP.

GlobeNewswire 1mo ago

CSCI.TO
+1.19%
CSCIF
COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment

GlobeNewswire 4mo ago

CSCI.TO
+1.19%
COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations

GlobeNewswire 6mo ago

CSCI.TO
+1.19%
CSCIF
COSCIENS Biopharma Inc. Reports Q2 2026 Results

GlobeNewswire 2mo ago

CSCI.TO
+1.19%
CSCIF
COSCIENS Biopharma Inc. Announces Results of Shareholder Meeting and Appointment of Full-Time CEO

GlobeNewswire 4mo ago

CSCI.TO
+1.19%
CSCI.NE

CSCIF
COSCIENS Biopharma Inc. Reports Q1 2026 Results

GlobeNewswire 5mo ago

CSCI.TO
+1.19%
CSCIF
COSCIENS Comments on Unusual Market Activity

GlobeNewswire 6mo ago

CSCI.TO
+1.19%
Upcoming Meeting Dates - March 23, 2026

TMX Newsfile 7mo ago

ARE.TO

ARGL.CN

CSCI.TO
+1.19%
COSCIENS Provides Strategic Update

GlobeNewswire 7mo ago

CSCI.TO
+1.19%

Performance Overview

Return	CSCI.TO	S&P/TSX Composite index (^GSPTSE)
YTD	-66.90%	+12.65%
1-Year	-73.26%	+18.63%
3-Year	-88.89%	+82.91%

Mobilize your Website

View Site in Mobile | Classic

Share by: